Pathology, the study of diseases, raises profound ethical considerations in both diagnosis and research. In diagnostic pathology, ethical frameworks emphasize accurate reporting, transparent communication with patients, and respecting patient autonomy in choosing diagnostic procedures. Discussions around the responsible use of genetic information and the potential implications for patients and their families underscore pathology. In research, ethical practices in pathology involve obtaining informed consent, ensuring data privacy, and maintaining the highest standards of scientific integrity. As pathology advances with technologies like digital pathology and artificial intelligence, ethical discourse remains central to navigating the evolving landscape while prioritizing patient welfare and upholding ethical responsibilities to society.
Pathological disorders, also known as pathological conditions or diseases, refer to abnormal conditions or dysfunctions in the body that disrupt normal physiological processes. These disorders can affect various organs, tissues, and systems, leading to deviations from normal structure or function. Pathological disorders can result from genetic factors, infections, environmental influences, lifestyle choices, or a combination of these.
Title : Overview of augmented intelligence for nursing
Adele Webb, Strategic Education, Inc., United States
Title : Equity in action: Amplifying your voice in nursing leadership
Robin Adams Geiger, Ingenovis Health, United States
Title : The relationship between empowerment and quality of health among clients with chronic health conditions
Ismat Mikky, Bloomfield College of Montclair State University, United States
Title : Healthcare system sponsored CNA training program creates opportunity and increases workforce
John R Balcuk, Northwell Health Huntington Hospital, United States
Title : Pathway-Aligned degrees: A strategic solution to the global nursing shortage
Maureen Kroning, SUNY Empire State University, United States
Title : The importance of assessing the patient experience of hypersensitivity reaction
Kerry Hennessy, Dana Farber Cancer Institute, United States